奥赛康:拟使用不超过12亿元自有资金委托理财

Core Viewpoint - The company has approved a plan to use idle self-owned funds for entrusted wealth management, allowing for investment in low-risk, liquid financial products issued by various financial institutions [1] Group 1 - The company will utilize up to 1.2 billion yuan of idle self-owned funds for this investment strategy [1] - The financial products will be sourced from banks, securities companies, trust companies, and fund management companies [1] - The decision was made during the seventh meeting of the seventh board of directors and does not require shareholder approval as it falls within the board's authority [1]

ASK PHARM-奥赛康:拟使用不超过12亿元自有资金委托理财 - Reportify